OptimizeRx Secures $35M Credit Facility from Fifth Third Bank

OptimizeRx (NASDAQ: OPRX), a leading healthcare technology company, has secured a $35 million senior credit facility from Fifth Third Bank. The facility includes a $25 million term loan and a $10 million revolving credit line, which was undrawn at closing. Roth Capital Partners acted as financial advisor for the transaction. This capital injection is expected to bolster OptimizeRx's ability to expand its innovative platform that connects life sciences brands with healthcare providers and patients. OptimizeRx is known for its AI-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT), which enable hyper-local and timely engagement, bridging the gap between HCP and DTC strategies to drive faster treatment decisions and improved patient outcomes. For more details, visit the full announcement at https://ibn.fm/G0Fj3.

OptimizeRx is headquartered in Waltham, Massachusetts, and partners with leading pharmaceutical and life sciences companies to transform healthcare. The company's commitment to privacy-safe, patient-centric technology ensures meaningful interactions, delivering therapies to the right patients at the right time. The news release was disseminated by MissionIR, a specialized communications platform within the Dynamic Brand Portfolio @ IBN, which offers services like wire solutions via InvestorWire, editorial syndication to 5,000+ outlets, press release enhancement, social media distribution, and corporate communications solutions. MissionIR helps companies gain visibility among investors, influencers, and the public. For more information, visit www.MissionIR.com.

This financial move positions OptimizeRx to further develop its technology and expand its market reach, potentially accelerating the adoption of its AI-driven marketing solutions in the life sciences sector. The credit facility provides the company with increased financial flexibility to invest in growth initiatives, including its DAAP and MNT platforms. As healthcare continues to digitalize, OptimizeRx's role in facilitating targeted, efficient communication between pharma brands and healthcare providers becomes increasingly vital, potentially improving patient outcomes and reducing time-to-treatment for critical therapies.